Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Renhe Partners with Applied Pharma to Market Migraine Drug in China

publication date: Jan 19, 2017
Renhe Group of Beijing has formed a partnership with Switzerland's Applied Pharma Research to distribute Diclofenac, a patented treatment for migraine, in China, Hong Kong, Macao and Taiwan. APR's product is a powder for oral solution. So far, migraines are not a major problem in China, but the two companies believe the condition may be under-diagnosed because it is uncommon. Over time, they expect the stresses of an increasingly urban China will also cause greater incidence. Financial details of the agreement were not disclosed. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital